NGX-4010 for the Treatment of Postherpetic Neuralgia
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of the study is determine if an investigational drug, NGX-4010
(high-concentration capsaicin dermal patches) is effective in treating pain associated with
post-herpetic neuralgia (PHN).